Leerink Partners Maintains Outperform on BrightSpring Health, Raises Price Target to $92
Benzinga Newsdesk 11 hours ago
Analyst RatingsNewsPrice Target
Leerink Partners analyst Whit Mayo maintains BrightSpring Health (NASDAQ:BTSG) with a Outperform and raises the price target from $72 to $92.
Leerink Partners analyst Whit Mayo maintains BrightSpring Health (NASDAQ:BTSG) with a Outperform and raises the price target from $72 to $92.